Filing Details
- Accession Number:
- 0001415889-23-005417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-24 21:35:32
- Reporting Period:
- 2023-03-22
- Accepted Time:
- 2023-03-24 21:35:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646649 | Jonathan Sheena | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-22 | 1,259 | $56.32 | 529,113 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-22 | 455 | $0.00 | 529,568 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-23 | 135 | $56.08 | 529,433 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2023-03-22 | 455 | $0.00 | 455 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 25,155 | Indirect | By Caraluna Trust 1 |
| Common Stock | 25,155 | Indirect | By Caraluna Trust 2 |
Footnotes
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and in compliance with Rule 10b5-1.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
- The RSUs vest over four years. 25% of the RSUs vested on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
